Variant report
Variant | nsv516030 |
---|---|
Chromosome Location | chr8:65250883-65256119 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10104164 | chr8:65250883-65250884 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs573611553 | chr8:65250949-65250950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543762978 | chr8:65250961-65250962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537291900 | chr8:65250990-65250991 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs562344937 | chr8:65250993-65250994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs544194262 | chr8:65250994-65250995 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187700003 | chr8:65251059-65251060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs190828401 | chr8:65251113-65251114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs560226801 | chr8:65251118-65251119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183907497 | chr8:65251120-65251121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs547232177 | chr8:65251149-65251150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146683315 | chr8:65251154-65251155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1866278 | chr8:65251178-65251179 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs74344177 | chr8:65251215-65251216 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs13439695 | chr8:65251218-65251219 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs576147648 | chr8:65251251-65251252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs542050165 | chr8:65251259-65251260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140217938 | chr8:65251310-65251311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs187968581 | chr8:65251317-65251318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs35117068 | chr8:65251371-65251372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35178727 | chr8:65251407-65251408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs566648494 | chr8:65251456-65251457 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs533701732 | chr8:65251504-65251505 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75804187 | chr8:65251508-65251509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150287776 | chr8:65251523-65251524 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs1898624 | chr8:65251562-65251563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs10957310 | chr8:65251572-65251573 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs556460231 | chr8:65251624-65251625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs577549903 | chr8:65251635-65251636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs137942224 | chr8:65251658-65251659 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs553557710 | chr8:65251664-65251665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs16931083 | chr8:65251708-65251709 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs149212440 | chr8:65251718-65251719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs146916395 | chr8:65251724-65251725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139230526 | chr8:65251743-65251744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs192600003 | chr8:65251745-65251746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs36056461 | chr8:65251751-65251752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs563226768 | chr8:65251780-65251781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34492521 | chr8:65251788-65251789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184462995 | chr8:65251813-65251814 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs298188 | chr8:65251877-65251878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533148651 | chr8:65251899-65251900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs143168343 | chr8:65251913-65251914 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566583347 | chr8:65251939-65251940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs187652701 | chr8:65252000-65252001 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112837843 | chr8:65252055-65252056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs549110067 | chr8:65252107-65252108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567112476 | chr8:65252114-65252115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs34117765 | chr8:65252124-65252125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191766775 | chr8:65252129-65252130 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:65249600-65260000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:65251400-65253800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr8:65253800-65254600 | Strong transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr8:65254200-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr8:65254400-65255600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
6 | chr8:65254600-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
7 | chr8:65254600-65257200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:65255200-65255400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |